Anzeige
Mehr »
Mittwoch, 13.05.2026 - Börsentäglich über 12.000 News
Kann Inspiration Mining die nächste 1.000 % Chance werden? Das Bohrprogramm startet in wenigen Tagen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40J1L | ISIN: CA22112H1010 | Ticker-Symbol: ET8
Stuttgart
12.05.26 | 15:02
1,360 Euro
0,00 % 0,000
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
COSCIENS BIOPHARMA INC Chart 1 Jahr
5-Tage-Chart
COSCIENS BIOPHARMA INC 5-Tage-Chart
RealtimeGeldBriefZeit
1,5101,57012.05.

Aktuelle News zur COSCIENS BIOPHARMA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
COSCIENS BIOPHARMA Aktie jetzt für 0€ handeln
DiCOSCIENS Biopharma Inc. GAAP EPS of -$0.06, revenue of $1.9M1
DiCOSCIENS Biopharma Inc. Reports Q1 2026 Results1
FrCOSCIENS Biopharma Inc. - 6-K, Report of foreign issuer2
21.04.Cosciens Biopharma Inc: Cosciens Biopharma to exit U.S. reporting10
20.04.COSCIENS Biopharma Inc. - 6-K, Report of foreign issuer-
07.04.Cosciens Biopharma Inc: Cosciens Biopharma does not say why shares are spiking19
07.04.COSCIENS Biopharma Inc.: COSCIENS Comments on Unusual Market Activity11
07.04.COSCIENS Biopharma Inc. - 6-K, Report of foreign issuer-
26.03.COSCIENS Biopharma Inc. GAAP EPS of -$0.69, revenue of $1.8M26
25.03.COSCIENS Biopharma Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update662TORONTO, ONTARIO, March 25, 2026 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (TSX: CSCI) (OTCQB: CSCIF) ("COSCIENS" or the "Company"), a life science company focused on the development of natural...
► Artikel lesen
25.03.COSCIENS Biopharma Inc. - 20-F, Annual and transition report of foreign private issuers1
25.03.COSCIENS Biopharma Inc. - 6-K, Report of foreign issuer1
06.03.Cosciens Biopharma Inc: Cosciens's German units to begin insolvency process15
05.03.COSCIENS Biopharma Inc.: COSCIENS Provides Strategic Update519TORONTO, ONTARIO, March 05, 2026 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (TSX: CSCI) (FINRA: CSCIF) ("COSCIENS" or the "Company") today announced that the Company has made a strategic decision...
► Artikel lesen
05.03.COSCIENS Biopharma Inc. - 6-K, Report of foreign issuer1
01.12.25COSCIENS Biopharma Inc.: COSCIENS Announces Exclusive Distribution Agreement with Wuzhou Drug International for Macrilen in Hainan-Guangdong-Hong Kong-Macao Greater Bay Area and Singapore7
01.12.25COSCIENS Biopharma Inc. - 6-K, Report of foreign issuer-
15.11.25Cosciens Biopharma Inc: Cosciens Biopharma appoints Puccetti as interim CFO4
14.11.25COSCIENS Biopharma Inc. Announces Leadership Change416TORONTO, ONTARIO, Nov. 14, 2025 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (TSX: CSCI) (FINRA: CSCIF) ("COSCIENS" or the "Company"), a life science company focused on natural ingredients and pharmaceutical...
► Artikel lesen
11.11.25COSCIENS Biopharma Inc. Reports Third Quarter 2025 Financial Results and Provides Strategic Initiatives Update336COSCIENS voluntarily delists from Nasdaq, while retaining the Company's listing on the TSX COSCIENS restructuring results in significantly lower cash outflow with operating expenses down 59% vs. Q3...
► Artikel lesen
Weiter >>
24 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,12